What is the current stock price of 4DMedical Limited (FDMDF)?

As of the latest market data, 4DMedical Limited (FDMDF) is trading at $2.25. The stock has seen a loss of 0.00% today.

Does 4DMedical Limited (FDMDF) pay a dividend?

Based on current data, 4DMedical Limited does not have a confirmed active dividend policy.

What is the market cap of 4DMedical Limited?

The current market capitalization of 4DMedical Limited (FDMDF) is approximately unavailable.

FDMDF

4DMedical Limited·Healthcare

2.25

0.000%(+0.00)

Close Price

2.42

7.556%(+0.17)

Pre-Market

Last Updated: — ET

52W L: $0.1652W H: $5.00

FDMDF NEWS

seekingalpha.com

May 21

4DMedical Limited (FDMDF) Discusses Clinical Use of CT:VQ in Patient Selection for Lung Volume Reduction Surgery Transcript

prnewswire.com

Mar 30

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 30, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union.

Company Profile

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.

Sector

Healthcare

Industry

Medical - Devices

Employees

145

IPO Date

2021-02-02

Beta

1.97

Websitewww.4dmedical.com↗